Leder, Benjamin Z <br/><br/>
Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.  [electronic resource] 

 -  Lancet (London, England)  Sep 2015 
 - 1147-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-547X 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(15)61120-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--administration & dosage<br/>Denosumab<br/>Drug Administration Schedule<br/>Drug Substitution<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Single-Blind Method<br/>Teriparatide--administration & dosage